Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,564,480
+$502,874 QoQ
Shares Held
14,165
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,534
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. ABBV ranks #1 (23.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,564,480 | 14,165 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,061,606 | 14,077 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,555,102 | 6,806 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,572,156 | 6,790 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $1,323,656 | 7,131 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,060,629 | 9,835 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,811,473 | 10,194 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,006,791 | 10,162 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,748,303 | 10,193 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,860,515 | 10,217 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,576,354 | 10,172 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,611,338 | 10,810 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,450,637 | 10,767 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,701,434 | 10,676 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,823,284 | 11,282 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,514,694 | 11,286 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,702,220 | 11,114 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,806,715 | 11,145 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,888,423 | 13,947 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,443,084 | 13,378 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,306,060 | 11,595 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $903,312 | 8,347 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $764,193 | 7,132 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $829,389 | 9,469 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $1,044,929 | 10,643 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $759,614 | 9,970 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||